Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 21.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,099 shares of the company's stock after acquiring an additional 2,311 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management owned 0.07% of Addus HomeCare worth $1,509,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in ADUS. GAMMA Investing LLC lifted its position in shares of Addus HomeCare by 10,307.8% during the first quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock worth $12,948,000 after acquiring an additional 129,672 shares in the last quarter. Rhumbline Advisers lifted its position in shares of Addus HomeCare by 1.3% during the first quarter. Rhumbline Advisers now owns 52,483 shares of the company's stock worth $5,190,000 after acquiring an additional 649 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Addus HomeCare during the first quarter worth $1,050,000. Azzad Asset Management Inc. ADV lifted its position in shares of Addus HomeCare by 14.1% during the first quarter. Azzad Asset Management Inc. ADV now owns 10,086 shares of the company's stock worth $997,000 after acquiring an additional 1,247 shares in the last quarter. Finally, Vista Finance LLC lifted its position in shares of Addus HomeCare by 7.0% during the first quarter. Vista Finance LLC now owns 2,994 shares of the company's stock worth $296,000 after acquiring an additional 195 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.
Insiders Place Their Bets
In other news, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the completion of the transaction, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. This trade represents a 11.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the transaction, the chief executive officer owned 166,461 shares of the company's stock, valued at $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,310 shares of company stock worth $3,958,375 over the last three months. Company insiders own 4.50% of the company's stock.
Analyst Upgrades and Downgrades
ADUS has been the topic of several research analyst reports. Macquarie reaffirmed an "outperform" rating and issued a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. Royal Bank Of Canada upped their price target on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a report on Friday, August 22nd. Stephens reaffirmed an "overweight" rating and issued a $140.00 price target on shares of Addus HomeCare in a report on Wednesday, September 3rd. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Wednesday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $138.89.
View Our Latest Report on Addus HomeCare
Addus HomeCare Trading Down 0.5%
NASDAQ ADUS opened at $114.86 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The stock has a 50 day simple moving average of $113.12 and a two-hundred day simple moving average of $109.29. The stock has a market cap of $2.12 billion, a P/E ratio of 25.36, a price-to-earnings-growth ratio of 1.75 and a beta of 0.86.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business had revenue of $349.44 million during the quarter, compared to analyst estimates of $345.71 million. During the same period last year, the business posted $1.35 earnings per share. Addus HomeCare's quarterly revenue was up 21.8% compared to the same quarter last year. On average, analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.
Addus HomeCare Company Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.